Eric Morand

Eric Morand serves as the Dean of the Sub-Faculty of Clinical and Molecular Medicine at Monash University since April 2011, overseeing comprehensive activities within the Monash Health network. Morand is also a Professor and Head of the School of Clinical Sciences, the largest clinical school within Monash's Faculty of Medicine Nursing and Health Sciences. In a parallel role at Monash Health since June 1992, Morand is the Director of Rheumatology, leading clinical research and administration in rheumatic diseases. Additional leadership roles include Board Member positions at Rare Voices Australia and Regenasome Pty Ltd, and serving as Chief Medical Officer at Wolf Biotherapeutics. Morand's educational background includes a PhD in Medicine from Monash University and FRACP qualifications in Internal Medicine and Rheumatology.